|
Online Database of Chemicals from Around the World | 产品搜索 | 产品提交 | 产品推广 |
网站主页 >> 化工产品目录 >> Pracinostat>> 市场分析报告 |
Pracinostat市场分析报告 |
|
MEI Pharma Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis ... of clinical drug candidates includes Pracinostat, ME-344 and ME-401. Pracinostat is an orally available histone ... and survival of hematologic cancer cells. Pracinostat has been tested in multiple Phase ... Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H2 2018 Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H2 2018 SUMMARY Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) pipeline Target constitutes close to 6 molecules. Out of which approximately 5 ... Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Drugs in Development, 2021 Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Drugs in Development, 2021 SUMMARY Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) pipeline Target constitutes close to 6 molecules. Out of which approximately 4 ... Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update SUMMARY According to the recently published report 'Histone Deacetylase 4 - ... Global Essential Thrombocythemia Drug Market Development Strategy Pre and Post COVID-19, by Corporate Strategy Analysis, Landscape, Type, Application, and Leading 20 Countries ... in this report are: Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Others Most widely ... Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H1 2018 Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) - Pipeline Review, H1 2018 SUMMARY Histone Deacetylase 4 (Histone Deacetylase A or HDAC4 or EC 3.5.1.98) pipeline Target constitutes close to 7 molecules. Out of which approximately 5 ... Global Essential Thrombocythemia Drug Market Report 2020 ... —— Product Type Segmentation Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Industry Segmentation Research ... Global Essential Thrombocythemia Drug Market Status, Trends and COVID-19 Impact Report 2022 ... —— Product Type Segment Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Application Segment Research ... Global Essential Thrombocythemia Drug Market Growth 2024-2030 ... value. Segmentation by type Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Others Segmentation by application ... Global Essential Thrombocythemia Drug Market Growth 2025-2031 ... countries. Segmentation by Type: Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Others Segmentation by Application ... Global Thrombocythaemia Myelofibrosis Treatment Market Growth (Status and Outlook) 2024-2030 ... historical data, market segmentation by Type (e.g., Pracinostat, Luminespib), and regional breakdowns. Market ... by Application in terms of value. Segmentation by type Pracinostat Luminespib Simtuzumab INCB-39110 Others ... Global Thrombocythaemia Myelofibrosis Treatment Market 2022 by Company, Regions, Type and Application, Forecast to 2028 ... at a % CAGR in next six years. While Pracinostat segment is altered to a % CAGR between 2022 ... markets. Market segment by Type, covers Pracinostat Luminespib Simtuzumab INCB-39110 Others ... Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H1 2018 Histone Deacetylase 2 (Transcriptional Regulator Homolog RPD3 or YY1 Associated Factor 1 or HDAC2 or EC 3.5.1.98) - Pipeline Review, H1 2018 SUMMARY According to the recently published report 'Histone Deacetylase 2 - Pipeline Review, H1 2018'; Histone ... Acute Myeloid Leukaemia:KOL Insight ... /Venclyxto (venetoclax), Helsinn/MEI Pharma’s pracinostat and Roche’s idasanutlin and reveal ... ) Venclexta/Venclyxto (venetoclax; AbbVie/Roche) pracinostat (Helsinn/MEI Pharma) idasanutlin (Roche ... Thrombocythaemia Myelofibrosis Treatment Market, Global Outlook and Forecast 2022-2028 ... China is Forecast to Reach $ Million by 2028. Pracinostat Segment to Reach $ Million by 2028, with ... Market Segment Percentages, by Type, 2021 (%) Pracinostat Luminespib Simtuzumab INCB-39110 Others ... Global Essential Thrombocythemia Drug Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031 ... . Market segment by Type Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Others Market segment ... Essential Thrombocythemia Drug Market, Global Outlook and Forecast 2022-2028 ... Percentages, by Type, 2021 (%) Givinostat Idasanutlin Pracinostat Ruxolitinib Phosphate Others Global Essential ... Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018 Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Pipeline Review, H1 2018 SUMMARY Histone Deacetylase 1 (HDAC1 or EC 3.5.1.98) - Histone deacetylase 1 is an enzyme encoded by the HDAC1 gene. The protein encoded by this gene belongs to the histone deacetylase ... Acute Myeloid Leukemia (AML) Therapeutics: Market Research Report This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the ... Histone deacetylase (HDAC) Inhibitors - Competitive Landscape, Market and Pipeline Analysis, 2017 This report can be delivered to the clients within 25 Hours DelveInsight’s, “Histone deacetylase (HDAC) Inhibitors - Competitive Landscape, Market, and Pipeline Analysis, 2017” report provides comprehensive insights of the ongoing therapeutic research and ... |